NCT02579837View on ClinicalTrials.gov

CLEAR SIGHT: A Trial of Non-Mydriatic Ultra-Widefield Retinal Imaging to Screen for Diabetic Eye Disease

NACompletedINTERVENTIONAL

Enrollment

742

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions

Diabetes MellitusDiabetic Retinopathy

Interventions

DEVICE

Optos 200Tx

non-mydriatic ultra-widefield (UWF) retinal imaging device

DEVICE

Zeiss Cirrus

optical coherence tomographer (OCT)

Trial Locations (1)

N6A 4V2

St. Joseph's Hospital, London

All Listed Sponsors

collaborator

The Physicians' Services Incorporated Foundation

OTHER

lead

Western University, Canada

OTHER

NCT02579837 - CLEAR SIGHT: A Trial of Non-Mydriatic Ultra-Widefield Retinal Imaging to Screen for Diabetic Eye Disease | Biotech Hunter | Biotech Hunter